Mini Review
Published on 26 Jun 2025
AI-driven innovation in antibody-drug conjugate design
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1628789
- 1,499 views
10 Publications
Editorial
Published on 10 Jun 2025
Editorial: Pharmacokinetics modeling in the Artificial Intelligence Era
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1636070
- 842 views
Original Research
Published on 06 Jun 2025
Dual upregulation of miRNA-143 and miRNA-506 in non-small cell lung cancer inhibits proliferation, motility, migration, and tumor growth
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1584801
- 809 views
Editorial
Published on 04 Jun 2025
Editorial: Enhancing drug discovery through structure-based design and computational techniques
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1632015
- 688 views
Original Research
Published on 30 May 2025
Safety and tolerability of a bevacizumab biosimilar (Effivia®) in adult Mexican patients with cancer: a multicenter, observational, prospective clinical study
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1591991
- 648 views
Original Research
Published on 15 Apr 2025
Identification of natural compounds as potential inhibitors of Interleukin-23: virtual screening, ADMET, drug-likeness, and dynamic simulation
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1525533
- 1,117 views
- 1 citation
Original Research
Published on 21 Feb 2025
Transduction of hematopoietic stem and progenitor cells by an MECP2 lentiviral vector improves Rett syndrome phenotypes
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1545391
- 941 views
Editorial
Published on 20 Feb 2025
Editorial: Exploring drug development with single cell omics analytics and stem cell-based disease models
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1561985
- 661 views
Perspective
Published on 19 Feb 2025
Perspective: How complex in vitro models are addressing the challenges of predicting drug-induced liver injury
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1536756
- 3,135 views
Review
Published on 29 Jan 2025
Non-enzymatic protein targeting agents as a promising strategy for cancer treatment
Frontiers in Drug Discovery
doi 10.3389/fddsv.2025.1520734
- 2,654 views